If a treatment isn't currently offered, you can register interest on hi-doctor.ai to be notified of future availability
I appreciate that the team calls me by name and remembers the details of my plan
For instance, numerous semaglutide trials in diabetic cohorts utilized the 1.0 mg dosage rather than the 2.4 mg dosage approved for obesity, inherently skewing relative efficacy assessments ( Both therapies exhibit favorable and comparable safety profiles, primarily characterized by transient gastrointestinal adverse events ( Conclusion Tirzepatide and semaglutide represent highly effective pharmacologic options for managing obesity and T2DM, with distinct clinical evidence profiles
doi: 10.1056/NEJMoa1616011
She specializes in adrenal, thyroid, and digestive disorders that often contribute to weight issues, treating conditions like obesity, Hashimotos, Crohns, and ulcerative colitis
Q: Can hot sauce replace my GLP-1 shot